Silver Sponsor

“Founded in 1997, Ergomed is a complete, global Phase I-IV clinical development and trial management service partner with leading expertise in developing rare diseases and oncology drugs. Pioneers in rare disease drug development since 1998, Ergomed embody a family & patient-centric approach to recruitment and retention with access to global patients in vital geographical areas. To further strengthen Ergomed CRO's strong operational footprint and expertise in rare diseases and oncology, Ergomed invested in a strategic US acquisition of MedSource CRO, fully integrated in early 2021. Ergomed has supported and managed clinical development, trial management, pharmacovigilance, and medical information services for over 300 clients in more than 100 countries. For more information about Ergomed, please visit:


World Orphan Drug Congress


The World Orphan Drug Congress provides you with a one stop progressive scientific and strategic solution to the orphan drugs industry.




World Orphan Drug Congress

Rare Disease Day



Contact us

To sponsor or exhibit:
Michael Hodge

To speak:
Wing-Yun Cheung

Nadia Konneh